Delivery Order SPE2DB20D3505-SPE2DB21FU5B4
- Not listed
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $1,591.02 for the supply of Sirolimus 1 mg tablets. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the...
- This federal contract award, valued at $1,315.24, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Sirolimus 1 mg tablets, a pharmaceutical product used in various medical treatments. The award is a Delivery Order under an Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through December 2025. This IDC serves...
- This federal contract award, with a ceiling value of $1,384.75, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Sirolimus 1 mg tablets and is a Firm Fixed Price Delivery Order, with an ultimate completion date of December 28, 2023. The contract is not designated as a set-aside award, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,207.29, is for the delivery of Sirolimus 1 mg tablets. The award falls under a larger Indefinite Delivery Contract (IDC) between Cencora, Inc. (the parent company of Amerisourcebergen Drug Corp) and the DLA, valued at up to $999,999,999.00 and running through December 2025. This IDC serves...
- This federal contract award is for the delivery of Sirolimus 1 mg tablets in quantities of 100 to the Defense Logistics Agency (DLA). The contract, valued at $3,012.92, was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The contract is a firm fixed-price delivery order with a completion date of January 12, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
- This federal contract award, valued at $1,995.13, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Sirolimus 1 mg/ml solution, a specialty medication, to support military treatment facilities, veterans' healthcare programs, and other federal medical institutions. The award is a delivery order issued under Amerisourcebergen's existing...
- This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of sirolimus 1 mg tablets. The single-award Indefinite Delivery Contract (IDC) with Amerisourcebergen has a ceiling value of $999,999,999.00 and runs through December 31, 2025. This contract serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical...
- This contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order under the Defense Logistics Agency (DLA) Troop Support Medical Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00. The contract provides for the delivery of various pharmaceutical products and medical supplies, including specialty medications, brand-name drugs, generic pharmaceuticals, and critical care materials such as syringes and test kits. This delivery order, valued at...
- The federal contract award is for the delivery of Sirolimus 1 mg tablets to the Defense Logistics Agency (DLA) under contract number SPE2DB20D3103|SPE2DB22FM0P7. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $2,959.29 and an ultimate completion date of December 22, 2021. It is a firm fixed-price delivery order contract with no set-aside designation, indicating open competition....
- This federal contract award, with an ID of SPE2DX15D1022|SPE2DX24FUZZT, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The award is for the delivery of 4562846298 SIROLIMUS 0.5 MG TABLET 100S, a pharmaceutical product, with a ceiling value of $1,038.12. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued...
- SPE2DB20D3505Indefinite Delivery Contract
- SPE2DB20D3505-SPE2DB21FU5B4Delivery Order
This federal contract award, valued at $1,783.96, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Sirolimus 1 mg/ml solution in 60ml containers. The award was made on a firm-fixed-price basis without any set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary vehicle for the company to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This contract encompasses critical medical commodities including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains. Additionally, Cencora, Inc. maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at up to $750,000, for similar medical products and prescription drugs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.8k | 9/29/21 |